Grifols (GRFS) Other Working Capital Changes (2010 - 2015)
Grifols (GRFS) posted Other Working Capital Changes of -$271.2 million for Q3 2015, down 603.31% quarter-over-quarter from $53.9 million in Q2 2015.
Grifols (GRFS) Other Working Capital Changes (2010 - 2015) Analysis & Trends
Grifols (GRFS) has reported Other Working Capital Changes for 5 consecutive years, with -$271.2 million the latest figure, recorded in Q3 2015.
- Other Working Capital Changes for Q3 2015 came in at -$271.2 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2015 was -$207.1 million (changed N/A YoY), and the FY2021 annual result was -$161.2 million, down 232.83% from the prior year.
- Other Working Capital Changes was -$271.2 million for Q3 2015 at Grifols, down from $53.9 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $205.2 million in Q3 2011 and troughed at -$312.4 million in Q4 2012.
- Average Other Working Capital Changes over 4 years is -$16.2 million, with a median of $3.9 million recorded in 2012.
- Year-over-year, Other Working Capital Changes slumped 306.27% in 2012 and jumped 72374.47% in 2013.
- Over 4 years, Other Working Capital Changes stood at -$76.9 million in 2011, then sank by 306.27% to -$312.4 million in 2012, then soared by 120.96% to $65.5 million in 2013, then plunged by 514.17% to -$271.2 million in 2015.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$271.2 million in Q3 2015, $53.9 million in Q2 2015, and -$55.2 million in Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Grifols | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 267.49 Mn |
| Dec 31, 2015 | 267.49 Mn |
| Dec 31, 2015 | 267.49 Mn |
| Sep 30, 2015 | -271.19 Mn |
| Sep 30, 2015 | -271.19 Mn |
| Sep 30, 2015 | -271.19 Mn |
| Jun 30, 2015 | 53.88 Mn |
| Jun 30, 2015 | 53.88 Mn |
| Jun 30, 2015 | 53.88 Mn |
| Mar 31, 2015 | -55.24 Mn |
| Mar 31, 2015 | -55.24 Mn |
| Mar 31, 2015 | -55.24 Mn |
| Dec 31, 2014 | -195.48 Mn |
| Dec 31, 2014 | -195.48 Mn |
| Dec 31, 2014 | -195.48 Mn |
| Sep 30, 2014 | 207.57 Mn |
| Sep 30, 2014 | 207.57 Mn |
| Sep 30, 2014 | 207.57 Mn |
| Jun 30, 2014 | -78.21 Mn |
| Jun 30, 2014 | -78.21 Mn |